I have to disagree with you on this one. What was the purpose of the update except to pump up those on the mailing list? What's with the press interviews that said nothing but I had this idea and it seems to work and if it does we would like to license it and apply for a patent and at some time in the near future issue a press release. My contention is to say nothing until you can back it up in a PR. We knew from the Ebola 2014 PR the N Assay had the potential to be reconfigured for (v) and it was sat on until the April Epiphany. Holding.